Results for "consumer data right"
231-240 of 573 results for 'consumer data right'
A big tick for tech: High Court declines to reopen patentability battle
On 5 February 2026, the High Court of Australia1 (Australia's ultimate appellate court) refused the Commissioner of Patent's application for special leave to appeal from the decision of the Full Court ...
ACCC calls for significant reforms to the Murray-Darling Basin water markets
The Australian Competition and Consumer Commission (ACCC) has released the final report of its inquiry into the Murray-Darling Basin (Basin) water markets. ...
Healthcare trend watch 2019
The healthcare team at Allens reports on some key trends and sectors to look out for in 2020. ...
PBS process proving a headache for migraine medications
Challenging a PBAC decision is not straightforward. We take a look at the available options and examine the alleged delays in listing migraine treatments Emgality and Ajovy on the PBS. ...
Class action risk: interim update
Filings are down, but impact too early to call. 2022 is shaping up as the year that bucks a number of long-running class action trends. Filings are materially down on prior years, and the claims that have been filed are somewhat at odds with recent trends. ...
Optus decision highlights challenges for privilege claims over investigation reports
Optus decision highlights challenges for privilege claims over investigation reports. ...
Making the quantum computing leap
The Federal Government's recent National Quantum Strategy and FY2023–24 Budget signal a strong commitment to growing Australia's quantum computing sector. To assist organisations aiming to capitalise on that renewed focus, this Insight gives an overview of the technology and the legal issues. ...
Takeaways from recent guidance on cyber incident disclosure obligations for listed companies
In this Insight, we examine the guidance note and related developments and offer our view as to when disclosure (for the purposes of the ASX listing rule requirements) of cyber incidents should generally only occur. ...
TGA guidance on the promotion of stem cells and HCT products
The Therapeutic Goods Administration has issued advertising guidance for businesses involved with stems cells and other human cell or tissue products. ...
Thriving in an era of scrutiny: Culture and conduct
Legal and compliance leaders should act now to combat serious and increasing legal and reputational risk ...